Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-05-28

Clinical Trial Update: Impulsivity and Thought Process Disorder in Patients With Active Suicidal Ideation and Depression [NA]

View source ↗

Summary

A clinical trial investigating impulsivity and thought process disorder in patients with active suicidal ideation and depression has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Impulsivity, Active Suicidal Ideation | NA | Status: WITHDRAWN